CEE Pharma & Healthcare Sector Report

CEE Pharma & Healthcare Sector Report 2026-27

The recently released industry report, titled CEE Pharma and Healthcare Sector Report 2026-2027 by EMIS Insights provides an in-depth analysis of the healthcare and pharmaceutical sectors across Central and Eastern European (CEE) countries comprising Poland, Czechia, Hungary, Romania, Slovakia, and Croatia.

The report examines demographic trends, health profiles, healthcare infrastructure, regulatory frameworks, AI adoption, and competitive landscapes within these markets.

he publication highlights the structural strains on CEE healthcare systems due to aging and shrinking populations, persistent behavioral risk factors, and workforce shortages, while also pointing to digital and AI-driven efficiency gains as key drivers for future development.

Get the trusted intelligence you need to stay ahead, with answers to questions including:


▪️How are birth- and mortality rates as well as old-age dependency ratios affecting the pharma and healthcare sector in CEE?

▪️What role is AI adoption playing in improving CEE healthcare, and who are the key investors? 

▪️What are the key EU legislative changes impacting CEE healthcare and pharmaceutical systems? 

▪️How are the pharma pricing policies in Poland and the recent ownership change of Czech Zentiva affect drug sales in the region?

The report offers much more on the dominant causes of death in CEE, the limits in the utilisation of hospital bed capacity, and the implications of high behavioral risk exposure and aging demographics for healthcare providers, amongst other issues.

Access the report to uncover the latest sector trends and developments.
Better insights. Better decisions. Better business.

Download Sample Report


Unlock Central and Eastern Europe’s market potential with EMIS CEE, our expanded product solution providing the verified data and analysis you need to make the right strategic, risk, and investment decisions.  
Request EMIS demo